+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis

Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis

American Journal of Pathology 184(5): 1369-1383

Idiopathic pulmonary fibrosis (IPF) is a progressive disease of the middle aged and elderly with a prevalence of one million persons worldwide. The fibrosis spreads from affected alveoli into contiguous alveoli, creating a reticular network that leads to death by asphyxiation. Lung fibroblasts from patients with IPF have phenotypic hallmarks, distinguishing them from their normal counterparts: pathologically activated Akt signaling axis, increased collagen and α-smooth muscle actin expression, distinct gene expression profile, and ability to form fibrotic lesions in model organisms. Despite the centrality of these fibroblasts in disease pathogenesis, their origin remains uncertain. Here, we report the identification of cells in the lungs of patients with IPF with the properties of mesenchymal progenitors. In contrast to progenitors isolated from nonfibrotic lungs, IPF mesenchymal progenitor cells produce daughter cells manifesting the full spectrum of IPF hallmarks, including the ability to form fibrotic lesions in zebrafish embryos and mouse lungs, and a transcriptional profile reflecting these properties. Morphological analysis of IPF lung tissue revealed that mesenchymal progenitor cells and cells with the characteristics of their progeny comprised the fibrotic reticulum. These data establish that the lungs of patients with IPF contain pathological mesenchymal progenitor cells that are cells of origin for fibrosis-mediating fibroblasts. These fibrogenic mesenchymal progenitors and their progeny represent an unexplored target for novel therapies to interdict fibrosis.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053660500

Download citation: RISBibTeXText

PMID: 24631025

DOI: 10.1016/j.ajpath.2014.01.012

Related references

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Respiratory Research 15: 157, 2014

Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases. Current Opinion in Pulmonary Medicine 19(5): 466-473, 2013

Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?. Lancet. Respiratory Medicine 6(2): 154-160, 2018

Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing. Respirology 24(10): 988-995, 2019

Smooth muscle hyperplasia in pulmonary fibrotic lesions is correlated with clubbing of fingers in idiopathic pulmonary fibrosis usual interstitial pneumonia. American Review of Respiratory Disease 143(4 Part 2): A51, 1991

Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications. Expert Review of Respiratory Medicine 10(6): 699-711, 2016

Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 197(11): 1443-1456, 2018

Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts. American Journal of Physiology. Lung Cellular and Molecular Physiology 312(6): L945-L958, 2017

Desensitization of idiopathic pulmonary fibrosis fibroblasts to Alternaria alternata extract-mediated necrotic cell death. Physiological Reports 4(21):, 2016

Considerations on the radiological aspects of idiopathic pulmonary fibrosis & of tuberculous fibrotic manifestations. Minerva Medica 50(39): 1517-1527, 1959

Fibrotic idiopathic interstitial pneumonia - the extent of pulmonary fibrosis predicts survival. Rofo 185(3): 206, 2013

Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy. Journal of Heart and Lung Transplantation 2017:, 2017

Significance of early intraalveolar fibrotic lesions in lung biopsies in idiopathic pulmonary fibrosis. American Review of Respiratory Disease 143(4 Part 2): A770, 1991

Nonresolving fibrotic disorders: idiopathic pulmonary fibrosis as a paradigm of impaired tissue regeneration. American Journal of the Medical Sciences 341(6): 431-434, 2011

PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. Jci Insight 4(6):, 2019